NalaGenetics recognised for its genetic tests to manage chronic diseases and will enter a four-month accelerator and receive up to US$100,000 in project funding.
Higher for longer rates predicted to help add US$1.5 trillion in global premiums by 2034, with advanced markets like Australia and Japan leading the surge.
'Stable' outlook driven by economic improvements and regulatory advancements, but concerns about higher risk retention and lack of agricultural reinsurance remain.
